** Shares of WuXi Biologics (Cayman) Inc 2269.HK drop 7.3% to HK$25.95, on track for the biggest one-day pct fall since April 7
** Stock hits the lowest since June 10, and on course to snap five consecutive sessions of gain
** Top pct loser on Hang Seng Biotech Index .HSHKBIO, which gains 0.5%
** The biologics discovery, development and manufacturing group said key shareholder WuXi Biologics Holdings plans sale of 2.04% stake for HK$2.21 bln ($281.55 mln) in share placement, reducing its stake in the firm to 12.32% from 14.36%
** The key shareholder plans sale of 82.94 mln existing shares at HK$26.60 each, or 5% discount to Friday's close of HK$28 each
** Hong Kong's healthcare index .HSCIH adds 0.3%, while Hang Seng Index .HSI slips 0.4%
** YTD, stock up 51.8% YTD
($1 = 7.8494 Hong Kong dollars)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。